The organizations plan to support clients
through expanded partnership and offer broader access to Medidata's
AI-powered technologies to accelerate clinical trial
development
TEANECK,
N.J., Jan. 30, 2025 /PRNewswire/ -- Cognizant
(Nasdaq: CTSH) announced an expanded agreement with Medidata, a
Dassault Systèmes brand and leader of clinical trial solutions to
the life sciences industry, to provide support for Medidata's life
sciences clients and expand the strategic alliance
partnership. Over the years, the companies have partnered to
deliver a comprehensive framework supporting life sciences clients,
emphasizing customer success, patient service desk, implementation,
engineering, integrations, and user acceptance testing services
using Medidata's clinical platform and solutions. The renewed
relationship aims to enhance responsiveness and improve user
satisfaction for life sciences organizations that rely on
Medidata's technology services for clinical trial development.
As part of the multi-year renewal agreement, Cognizant is
providing a dedicated team of Medidata Platform specialists to
support their clients in pharmaceutical, biotech, medical device,
contract research organizations, and patients using Medidata
services. The goal is to maximize Medidata's value for life
sciences clients. The collaboration aims to improve the experience
for Medidata's users, enabling their clients to focus on clinical
trial development and improving patient outcomes.
"Our partnership with Cognizant represents a shared commitment
to transforming clinical research through innovation and
expertise," said Janet Butler, EVP,
Head of Global Sales, of Medidata. "By combining Medidata's
advanced AI-driven technologies with Cognizant's deep industry
knowledge and operational excellence, we support life sciences
organizations to streamline their R&D efforts, derive
actionable insights from complex data, and ultimately bring
life-changing therapies to patients more efficiently."
Cognizant and Medidata are deepening their multi-year
collaboration with the goal to accelerate clinical trial
development by expanding access to Medidata's AI-powered
technologies. When combined with Medidata Clinical Data Studio,
Medidata Health Record Connect, and the myMedidata patient portal,
these solutions are helping to transform R&D with tailored
patient, site, and data experiences. As a top Global Medidata
Strategic Alliance Partner, Cognizant is leveraging its extensive
network of Medidata Certified Services Professionals to help life
sciences organizations modernize clinical operations and data
management.
"We are thrilled to accelerate our work with Medidata to help
mutual clients leverage next-generation AI-enabled clinical
capabilities on the unified Medidata Platform," said Mohammad Haque, SVP, Global Large Deals Lead and
Business Unit Head, Life Sciences, of Cognizant. "Our collaboration
aims to unlock the full potential of clients' clinical data and
processes, improving user satisfaction and empowering them to make
better-informed decisions faster for improved patient
outcomes."
About Cognizant
Cognizant (Nasdaq: CTSH) engineers
modern businesses. We help our clients modernize technology,
reimagine processes and transform experiences so they can stay
ahead in our fast-changing world. Together, we're improving
everyday life. See how at www.cognizant.com or @cognizant.
For more information, contact:
Natalie Steffen
Natalie.Steffen@cognizant.com
300 Frank W. Burr Blvd. Suite 36, 6th Floor
Teaneck, NJ 07666 USA
+1 201 801 0233 Cognizant.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cognizant-collaborates-with-medidata-to-provide-specialized-support-for-life-sciences-clients-302363839.html
SOURCE Cognizant Technology Solutions Corporation
